RUBY - Rubius Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts6356
Avg. Estimate-0.6-0.65-2.16-2.49
Low Estimate-0.68-0.66-2.2-2.94
High Estimate-0.41-0.63-2.13-1.62
Year Ago EPS-0.35-0.42-2.27-2.16
Revenue EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts5266
Avg. EstimateN/AN/AN/AN/A
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/AN/A
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History12/30/20183/30/20196/29/20199/29/2019
EPS Est.-0.42-0.38-0.45-0.53
EPS Actual-0.35-0.42-0.5-0.59
Difference0.07-0.04-0.05-0.06
Surprise %16.70%-10.50%-11.10%-11.30%
EPS TrendCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Current Estimate-0.6-0.65-2.16-2.49
7 Days Ago-0.6-0.65-2.16-2.49
30 Days Ago-0.6-0.65-2.16-2.49
60 Days Ago-0.6-0.65-2.16-2.49
90 Days Ago-0.57-0.54-2.02-2.32
EPS RevisionsCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesRUBYIndustrySectorS&P 500
Current Qtr.-71.40%N/AN/A0.01
Next Qtr.-54.80%N/AN/A0.06
Current Year4.80%N/AN/A-0.02
Next Year-15.30%N/AN/A0.14
Next 5 Years (per annum)N/AN/AN/A0.08
Past 5 Years (per annum)N/AN/AN/AN/A